REQUEST A DEMO
Total
USD $0.00
Search more companies

Viatris Korea (South Korea)

Main Activities: Wholesale Trade | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Viatris Korea Profile Updated: October 27, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Pfizer Pharmaceuticals Korea is a pharmaceutical company. The company operates in the pharmaceutical industry, focusing on the development and production of medicines, vaccines, and therapies for various diseases. Pfizer offers a range of products, including injections, tablets, and solutions for cancer treatment, hormone therapy, and infectious disease treatment. The company has a strong focus on research and development, with a team working on innovative new medicines. Pfizer Pharmaceuticals Korea is a global player in the pharmaceutical industry, with a commitment to finding valuable medical solutions. The company also engages in partnerships with academic experts and other bio-pharmaceutical companies to promote research and development activities. Pfizer Pharmaceuticals Korea has a diverse workforce and is dedicated to providing a stable work environment for its employees.

Headquarters
B-dong, 15th Floor, 14, Sejong-daero Jung-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Viatris Korea report to view the information.

Website: http://www.pfizer.co.kr

Basic Information
Total Employees:
Purchase the Viatris Korea report to view the information.
Outstanding Shares:
Purchase the Viatris Korea report to view the information.
Registered Capital:
Purchase the Viatris Korea report to view the information.
Incorporation Date:
May 27, 2019
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Viatris Korea report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
11.03%
Total operating revenue
11.03%
Operating profit (EBIT)
75.85%
Net Profit (Loss) for the Period
21.48%
Total assets
3.55%
Total equity
53.53%
Operating Profit Margin (ROS)
2.88%
Net Profit Margin
0.56%
Return on Equity (ROE)
-5.27%
Quick Ratio
0.27%
Cash Ratio
-0.13%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?